Thanks @Mangoman605.
From my perspective the staged approach whilst protracted help mitigate the risk of missing primary end points and the end of 002-003. Stage 1 has now confirmed 2mg/kg x 1 and 1.5mg/kg x 2 is NOT the minimum effective dose. The known and preferred dose used in OA008, 2B and SAS of 2mg/kg x 2 is both effective and still SAFE. Interestingly also the combined n for these prior trials using 2mg/kg x 2 all showing statistical significance on primary end points being used on OA002-003 is greater than the proposed Stage 2 n.
So we now wait for FDA to confirm we're good to move to preferred and known dosage of 2mg/kg x 2 for Stage 2.
- Forums
- ASX - By Stock
- PAR
- Ann: PAR Successful Placement and Fully Underwritten ANREO
Ann: PAR Successful Placement and Fully Underwritten ANREO, page-192
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.0¢ |
Change
-0.005(1.69%) |
Mkt cap ! $101.4M |
Open | High | Low | Value | Volume |
29.0¢ | 29.3¢ | 28.0¢ | $57.32K | 198.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 12454 | 28.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 4443 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 12454 | 0.285 |
8 | 157001 | 0.280 |
3 | 98402 | 0.275 |
6 | 72999 | 0.270 |
4 | 21233 | 0.260 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 4443 | 1 |
0.295 | 204237 | 3 |
0.300 | 203651 | 5 |
0.305 | 2600 | 1 |
0.310 | 50370 | 4 |
Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |